Decreased production of interleukin-10 and transforming growth factor-β in Toll-like receptor-activated intestinal B cells in SAMP1/Yit mice

Immunology

Volumn 131, Issue 4, 2010, Pages 473-487

  Mishima, Yoshiyuki ^a   Ishihara, Shunji ^a   Aziz, Md Monowar ^a   Oka, Akihiko ^a   Kusunoki, Ryusaku ^a   Otani, Aya ^a   Tada, Yasumasa ^a   Li, Yong Yu ^a   Moriyama, Ichiro ^a   Oshima, Naoki ^a   Yuki, Takafumi ^b   Amano, Yuji ^b   Matsumoto, Satoshi ^c   Kinoshita, Yoshikazu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b SHIMANE UNIVERSITY HOSPITAL   (Japan)

^c YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Crohn's disease; Interleukin 10; Regulatory B cells; Toll like receptor; Transforming growth factor

Indexed keywords

CD1D ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CELL SURFACE MARKER; DNA; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL STIMULATION; CELL SUBPOPULATION; CELLULAR IMMUNITY; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME IMMUNOASSAY; FLOW CYTOMETRY; ILEITIS; INTESTINE CELL; LYMPHOCYTE FUNCTION; MALE; MESENTERY LYMPH NODE; MONONUCLEAR CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, DIFFERENTIATION; B-LYMPHOCYTES; CROHN DISEASE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; ILEITIS; ILEUM; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MACROPHAGES; MESENTERY; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; SPECIES SPECIFICITY; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA1;

EID: 78149402882     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03318.x     Document Type: Article

References (57)

1. Sands BE. Inflammatory bowel disease: past, present, and future. J Gastroenterol 2007; 42:16-25.
2. Hibi T, Ogata H. Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol 2006; 41:10-6.
3. Ishihara S, Aziz MM, Yuki T, Kazumori H, Kinoshita Y. Inflammatory bowel disease: review from the aspect of genetics. J Gastroenterol 2009; 44:1097-108.
4. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3:521-33.
5. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411:599-603.
6. Cario E. Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut 2005; 54:1182-93.
7. Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J Immunol 2005; 174:4453-60.
8. Hampe J, Franke A, Rosenstiel P et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007; 39:207-11.
9. Wild GE, Rioux JD. Genome scan analyses and positional cloning strategy in IBD: successes and limitations. Best Pract Res Clin Gastroenterol 2004; 18:541-53.
10. Budarf ML, Labbé C, David G, Rioux JD. GWA studies: rewriting the story of IBD. Trends Genet 2009; 25:137-46.
11. Xavier RJ, Rioux JD. Genome-wide association studies: a new window into immune-mediated diseases. Nat Rev Immunol 2008; 8:631-43.
12. Duerr RH, Taylor KD, Brant SR et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314:1461-3.
13. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406:782-7.
14. Ishihara S, Rumi MA, Ortega-Cava CF, Kazumori H, Kadowaki Y, Ishimura N, Kinoshita Y. Therapeutic targeting of toll-like receptors in gastrointestinal inflammation. Curr Pharm Des 2006; 12:4215-28.
15. Medzhitov R Jr, Janeway CA. Decoding the patterns of self and nonself by the innate immune system. Science 2002; 296:298-300.
16. Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol 2008; 43:1-17.
17. + lamina propria dendritic cells in enterobacterial infection. J Gastroenterol 2009; 44:803-11.
18. Kanai T, Nemoto Y, Kamada N, Totsuka T, Hisamatsu T, Watanabe M, Hibi T. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease. Curr Opin Gastroenterol 2009; 25:306-13.
19. Boden EK, Snapper SB. Regulatory T cells in inflammatory bowel disease. Curr Opin Gastroenterol 2008; 24:733-41.
20. + memory T cells causes inflammatory bowel diseases to become intractable. Inflamm Bowel Dis 2009; 15:926-34.
21. Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol 2006; 176:705-10.
22. Mauri C, Ehrenstein MR. The 'short' history of regulatory B cells. Trends Immunol 2008; 29:34-40.
23. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002; 16:219-30.
24. Mizoguchi E, Mizoguchi A, Preffer FI, Bhan AK. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol 2000; 12:597-605.
25. Lund FE. Cytokine-producing B lymphocytes - key regulators of immunity. Curr Opin Immunol 2008; 20:332-8.
26. Lampropoulou V, Hoehlig K, Roch T et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol 2008; 180:4763-73.
27. Peng SL. Signaling in B cells via Toll-like receptors. Curr Opin Immunol 2005; 17:230-6.
28. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004; 22:929-79.
29. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002; 3:944-50.
30. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 2003; 197:489-501.
31. Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 2001; 167:1081-9.
32. Yanaba K, Bouaziz JD, Matsushita T, Magro CM, St Clair EW, Tedder TF. B-lymphocyte contributions to human autoimmune disease. Immunol Rev 2008; 223:284-99.
33. Bouaziz JD, Yanaba K, Tedder TF. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 2008; 224:201-14.
34. Moritoki Y, Zhang W, Tsuneyama K et al. B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis. Gastroenterology 2009; 136:1037-47.
35. Kurosaki T. Paradox of B cell-targeted therapies. J Clin Invest 2008; 118:3260-3.
36. Matsumoto S, Okabe Y, Setoyama H et al. Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut 1998; 43:71-8.
37. Burns RC, Rivera-Nieves J, Moskaluk CA, Matsumoto S, Cominelli F, Ley KF. Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease. Gastroenterology 2001; 121:1428-36.
38. Kosiewicz MM, Nast CC, Krishnan A, Rivera-Nieves J, Moskaluk CA, Matsumoto S, Kozaiwa K, Cominelli F. Th1-type responses mediate spontaneous ileitis in a noashi Hvel murine model of Crohn's disease. J Clin Invest 2001; 107:695-702.
39. Nagai Y, Kobayashi T, Motoi Y et al. The radioprotective 105/MD-1 complex links TLR2 and TLR4/MD-2 in antibody response to microbial membranes. J Immunol 2005; 174:7043-9.
40. Divanovic S, Trompette A, Atabani SF et al. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol 2005; 6:571-8.
41. Strober W, Nakamura K, Kitani A. The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease. J Clin Invest 2001; 107:667-700.
42. + phenotype controls T cell-dependent inflammatory responses. Immunity 2008; 28:639-50.
43. Olson TS, Bamias G, Naganuma M et al. Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. J Clin Invest 2004; 114:389-98.
44. Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 1996; 184:2271-8.
45. Cross AH, Trotter JL, Lyons J. B cells and antibodies in CNS demyelinating disease. J Neuroimmunol 2001; 112:1-14.
46. -/- mice in the absence of elevated proinflammatory cytokine response in the central nervous system. J Immunol 2002; 168:3105-12.
47. Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008; 118:3420-30.
48. Evans JG, Chavez-Rueda KA, Eddaoudi A, Meyer-Bahlburg A, Rawlings DJ, Ehrenstein MR, Mauri C. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 2007; 178:7868-78.
49. Lenert P, Brummel R, Field EH, Ashman RF. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol 2005; 25:29-40.
50. Hussain S, Delovitch TL. Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J Immunol 2007; 179:7225-32.
51. Knoechel B, Lohr J, Kahn E, Abbas AK. The link between lymphocyte deficiency and autoimmunity: roles of endogenous T and B lymphocytes in tolerance. J Immunol 2005; 175:21-6.
52. Bhan AK, Mizoguchi E, Smith RN, Mizoguchi A. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol Rev 1999; 169:195-207.
53. Mizoguchi E, Xavier RJ, Reinecker HC, Uchino H, Bhan AK, Podolsky DK, Mizoguchi A. Colonic epithelial functional phenotype varies with type and phase of experimental colitis. Gastroenterology 2003; 125:148-61.
54. Mizoguchi A, Mizoguchi E, Smith RN, Preffer FI, Bhan AK. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med 1997; 186:1749-56.
55. Dalwadi H, Wei B, Schrage M, Spicher K, Su TT, Birnbaumer L, Rawlings DJ, Braun J. B cell developmental requirement for the G alpha i2 gene. J Immunol 2003; 170:1707-15.
56. + T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci U S A 2005; 102:2010-5.
57. Yanaba K, Bouaziz JD, Matsushita T et al. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 2009; 182:7459-72.